Information Provided By: 
Fly News Breaks for September 11, 2017
DGX, LH
Sep 11, 2017 | 07:45 EDT
Canaccord analyst Mark Massaro raised his price target on LabCorp (LH) to $180 from $175 and said it remains one of his top five picks for 2017. Massaro said the stock's valuation remains below competitor Quest Diagnostics (DGX) and he believes investors should own shares in both companies. He noted LabCorp completed its acquisition of Chiltern, which he estimates can be accretive to earnings in year one. Massaro reiterated his Buy rating on LabCorp. shares.
News For LH;DGX From the Last 2 Days
There are no results for your query LH;DGX
